.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Queensland Health
QuintilesIMS
Moodys
Medtronic
UBS
Cerilliant
US Army
Teva

Generated: February 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 03100882

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-001May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-002May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-003May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist